Rodi, M.; de Lastic, A.-L.; Panagoulias, I.; Aggeletopoulou, I.; Kelaidonis, K.; Matsoukas, J.; Apostolopoulos, V.; Mouzaki, A.
Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. Int. J. Mol. Sci. 2024, 25, 6092.
https://doi.org/10.3390/ijms25116092
AMA Style
Rodi M, de Lastic A-L, Panagoulias I, Aggeletopoulou I, Kelaidonis K, Matsoukas J, Apostolopoulos V, Mouzaki A.
Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. International Journal of Molecular Sciences. 2024; 25(11):6092.
https://doi.org/10.3390/ijms25116092
Chicago/Turabian Style
Rodi, Maria, Anne-Lise de Lastic, Ioannis Panagoulias, Ioanna Aggeletopoulou, Kostas Kelaidonis, John Matsoukas, Vasso Apostolopoulos, and Athanasia Mouzaki.
2024. "Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis" International Journal of Molecular Sciences 25, no. 11: 6092.
https://doi.org/10.3390/ijms25116092
APA Style
Rodi, M., de Lastic, A. -L., Panagoulias, I., Aggeletopoulou, I., Kelaidonis, K., Matsoukas, J., Apostolopoulos, V., & Mouzaki, A.
(2024). Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. International Journal of Molecular Sciences, 25(11), 6092.
https://doi.org/10.3390/ijms25116092
